AMY-101 Uses, Dosage, Side Effects and more
AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
| Trade Name | AMY-101 |
| Generic | AMY-101 |
| Type | |
| Formula | C83H117N23O18S2 |
| Weight | Average: 1789.11 Monoisotopic: 1787.838836367 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
